Stay updated on Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer updates include the addition of 'Revision: v3.3.3' and the removal of the 'HHS Vulnerability Disclosure' link along with the earlier 'Revision: v3.3.2' label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:13:16.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Added a note that publications are auto-filled from PubMed and updated the revision to v3.3.2; the previous PubMed-origin note and v3.2.0 revision were removed.
    Difference
    0.1%
    Check dated 2025-11-24T16:51:55.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. The study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T14:59:33.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    No substantive changes detected in the study record between the two screenshots. The page continues to display the same study title, conditions, eligibility criteria, and planned interventions.
    Difference
    0.5%
    Check dated 2025-11-03T01:30:54.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-05T10:18:41.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.